YANG, DI
 Distribuzione geografica
Continente #
NA - Nord America 197
AS - Asia 92
EU - Europa 62
SA - Sud America 33
AF - Africa 2
Totale 386
Nazione #
US - Stati Uniti d'America 194
SE - Svezia 30
SG - Singapore 28
BR - Brasile 27
CN - Cina 21
HK - Hong Kong 20
VN - Vietnam 10
BG - Bulgaria 6
IT - Italia 6
TR - Turchia 5
DE - Germania 4
RU - Federazione Russa 4
AR - Argentina 3
BD - Bangladesh 3
CL - Cile 3
FR - Francia 3
AT - Austria 2
CA - Canada 2
FI - Finlandia 2
GB - Regno Unito 2
UA - Ucraina 2
AE - Emirati Arabi Uniti 1
CI - Costa d'Avorio 1
ID - Indonesia 1
IN - India 1
JP - Giappone 1
MA - Marocco 1
MX - Messico 1
PL - Polonia 1
SA - Arabia Saudita 1
Totale 386
Città #
Ann Arbor 38
Woodbridge 24
Fairfield 20
Hong Kong 20
Santa Clara 16
Ashburn 15
Seattle 15
Singapore 11
Houston 9
Cambridge 6
Shanghai 6
Sofia 6
Wilmington 6
Beijing 5
Boardman 4
Dallas 4
São Paulo 4
Belo Horizonte 3
Florence 3
New York 3
Ankara 2
Chandler 2
Des Moines 2
Düsseldorf 2
Haiphong 2
Hanoi 2
Ho Chi Minh City 2
Istanbul 2
Lawrence 2
Medford 2
Princeton 2
Redondo Beach 2
Santiago 2
Abidjan 1
Almeirim Municipality 1
Atlanta 1
Boa Vista 1
Buffalo 1
Campina Grande 1
Campo Grande 1
Changsha 1
Ciudad Evita 1
Congonhas 1
Contagem 1
Cravinhos 1
Croydon 1
Cuautitlán Izcalli 1
Dhaka 1
Dubai 1
Fuzhou 1
Grafing 1
Guapimirim 1
Itapira 1
Kastamonu 1
Kunming 1
London 1
Los Angeles 1
Medina 1
Milan 1
Mumbai 1
Nanchang 1
Nanjing 1
Neuquén 1
Nova Iguaçu 1
Nuremberg 1
Orem 1
Osasco 1
Ottawa 1
Perm 1
Phoenix 1
Porto Alegre 1
Ribeirão Preto 1
Rio de Janeiro 1
Salgueiro 1
San Diego 1
Santa Isabel 1
Santana do Livramento 1
Stockholm 1
São José dos Campos 1
Talcahuano 1
Thái Bình 1
Thái Nguyên 1
Tokyo 1
Vitória 1
Viçosa 1
Warsaw 1
Xiamen 1
Totale 298
Nome #
Variations in genes regulating tumor-associated macrophages (TAMs) to predict outcomes of bevacizumab-based treatment in patients with metastatic colorectal cancer: Results from TRIBE and FIRE3 trials 176
Genes involved in pericyte-driven tumor maturation predict treatment benefit of first-line FOLFIRI plus bevacizumab in patients with metastatic colorectal cancer 151
Genetic variants of DNA repair-related genes predict efficacy of TAS-102 in patients with refractory metastatic colorectal cancer 64
Totale 391
Categoria #
all - tutte 1.118
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.118


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20218 0 0 0 0 0 0 0 0 3 2 2 1
2021/202236 2 0 0 6 8 3 0 1 2 3 2 9
2022/202325 8 4 2 0 1 2 4 0 1 0 3 0
2023/202420 0 1 5 0 6 2 3 0 0 0 0 3
2024/202591 0 3 4 6 9 9 8 6 8 11 8 19
2025/202680 4 18 16 19 14 9 0 0 0 0 0 0
Totale 391